Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Agenus

AGEN

----

OverviewOverview OptionsOptions NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

M&A, Poison Pills, and Capital Restructuring Drive US Mid-Cap Realignments
Global Report·56 minutes ago
DKL-0.99%CISS-45.94%
Top Biotech Gainers: ADVB Soars Over 200% In A Week, NVCR, MEDP Report Q2 Results, AGMB In Focus
rttnews·1 day ago, 10:24 PM
NVCR-11.71%MEDP-0.73%
Agenus Announces Three BOT+BAL Presentations Spanning Neoadjuvant and Late-Line Colorectal Cancer and Advanced Sarcomas at ESMO 2026 | AGEN Stock News
StockTitan·Jul 17 at 01:28 AM
AGEN-3.39%
Why Is Agenus Stock Falling on Tuesday?
benzinga_article·Jul 14 at 10:37 AM
AGEN-3.39%
Top Biotech Gainers: QTTB Sends Strong SIGNAL; AMWL And SI In Focus
rttnews·Jul 13 at 09:35 PM
AGEN-3.39%SI+0.54%
Oracle, Twin Vee PowerCats, Agenus, Micron Technology and SanDisk: Why These 5 Stocks Are on Investors' Radars Today
benzinga_article·Jul 13 at 08:34 PM
VEEE-10.55%MU-6.99%
AGEN: Secured $340M to advance Phase 3 BOT + BAL trial in MSS colon cancer, targeting major market
Quartr·Jul 13 at 06:04 AM
AGEN-3.39%
Agenus Jumps 99% on $340M Raise for Phase 3 Colon Cancer Trial
US Stock Market Update·Jul 13 at 12:51 PM
AGEN-3.39%
12 Health Care Stocks Moving In Monday's Intraday Session
benzinga_article·Jul 13 at 12:05 PM
BIVI-4.86%QTTB-1.50%
Why Is Agenus Stock Gaining Monday?
benzinga_article·Jul 13 at 10:29 AM
AGEN-3.39%
Agenus soars 107% on $340 million private placement for drug trials
US Stock Market Update·Jul 13 at 10:22 AM
AGEN-3.39%
STOCKS | MGM Rises on Takeover Bid Report; SK Hynix Falls on Memory Pullback
CoinLive·Jul 13 at 09:45 AM
AGEN-3.39%MGM+1.22%
Agenus Stock Soars Over 100% as BATTMAN Takes a Back Seat to ROBBIN
benzinga_article·Jul 13 at 09:28 AM
AGEN-3.39%
Apple Surges to Record High as Semiconductor Stocks Slide Broadly
Market Pulse·Jul 13 at 09:24 AM
AAPL+3.53%NVDA-0.92%
Agenus Announces Oversubscribed Private Placement of Up to $340 Million to Advance Registrational ROBBIN Trial of Neoadjuvant BOT+BAL in MSS Colon Cancer | AGEN Stock News
StockTitan·Jul 12 at 09:00 PM
AGEN-3.39%